相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of small molecule HIV-1 integrase dimerization inhibitors
Cristina Tintori et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
Manuel Tsiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
Jacques J. Kessl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
Jean-Michel Molina et al.
LANCET INFECTIOUS DISEASES (2012)
Elvitegravir: a once daily alternative to raltegravir
Belete Ayele Desimmie et al.
LANCET INFECTIOUS DISEASES (2012)
LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs
Rik Schrijvers et al.
PLOS PATHOGENS (2012)
Development of an AlphaScreen-Based HIV-1 Integrase Dimerization Assay for Discovery of Novel Allosteric Inhibitors
Jonas Demeulemeester et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients - Impact of HIV subtypes and prior raltegravir experience
Carolina Garrido et al.
ANTIVIRAL RESEARCH (2011)
In Vitro DNA Tethering of HIV-1 lntegrase by the Transcriptional Coactivator LEDGF/p75
Melissa McNeely et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
FRET analysis reveals distinct conformations of IN tetramers in the presence of viral DNA or LEDGF/p75
Jacques J. Kessl et al.
NUCLEIC ACIDS RESEARCH (2011)
Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1
Romuald Corbau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Activity of Elvitegravir, a Once-Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose-Ranging Clinical Trial
Andrew R. Zolopa et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Retroviral intasome assembly and inhibition of DNA strand transfer
Stephen Hare et al.
NATURE (2010)
Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication
Frauke Christ et al.
NATURE CHEMICAL BIOLOGY (2010)
HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention
Wade S. Blair et al.
PLOS PATHOGENS (2010)
An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule
Jacques J. Kessl et al.
MOLECULAR PHARMACOLOGY (2009)
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro
Isabelle Malet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
A 1,536-well [35S] GTPγS scintillation proximity binding assay for ultra-high-throughput screening of an orphan Gαi-coupled GPCR
Eric N. Johnson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2008)
Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants
Jessica Marinello et al.
BIOCHEMISTRY (2008)
Discovery of Raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection
Vincenzo Summa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Broad Antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)
Kazuya Shimura et al.
JOURNAL OF VIROLOGY (2008)
Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase
John M. Murray et al.
AIDS (2007)
HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications
Gary P. Wang et al.
GENOME RESEARCH (2007)
LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration
Ming-Chieh Shun et al.
GENES & DEVELOPMENT (2007)
Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium
Zvi Hayouka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV
Anneleen Hombrouck et al.
PLOS PATHOGENS (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication
Jan De Rijck et al.
JOURNAL OF VIROLOGY (2006)
An essential role for LEDGF/p75 in HIV integration
Manuel Llano et al.
SCIENCE (2006)
Retroviral DNA integration: Viral and cellular determinants of target- site selection
Mary K. Lewinski et al.
PLOS PATHOGENS (2006)
Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus
L Vandekerckhove et al.
JOURNAL OF VIROLOGY (2006)
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
P Cherepanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication
S Emiliani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding
K Busschots et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering
M Vanegas et al.
JOURNAL OF CELL SCIENCE (2005)
Identification and characterization of a functional nuclear localization signal in the HIV-1 integrase interactor LEDGF/p75
G Maertens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase
P Cherepanov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells
P Cherepanov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase
AS Espeseth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding
JCH Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
CJ Petropoulos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
